Lumos Pharma | NLNK - Market Capitalization


Lumos Pharma reported $21.8M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Alterity Therapeutics Limited AUD 36M 20M Jun/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Celldex Therapeutics USD 2.11B 307M Mar/2026
Cipla INR 988.89B 231.9B Mar/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Incyte USD 18.73B 660M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026
Pfizer USD 153.81B 12.24B Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026